227 related articles for article (PubMed ID: 22911824)
1. Fra-1/AP-1 transcription factor negatively regulates pulmonary fibrosis in vivo.
Rajasekaran S; Vaz M; Reddy SP
PLoS One; 2012; 7(7):e41611. PubMed ID: 22911824
[TBL] [Abstract][Full Text] [Related]
2. Expression profiling of genes regulated by Fra-1/AP-1 transcription factor during bleomycin-induced pulmonary fibrosis.
Rajasekaran S; Reddy NM; Zhang W; Reddy SP
BMC Genomics; 2013 Jun; 14():381. PubMed ID: 23758685
[TBL] [Abstract][Full Text] [Related]
3. The role of the receptor for advanced glycation end-products in lung fibrosis.
He M; Kubo H; Ishizawa K; Hegab AE; Yamamoto Y; Yamamoto H; Yamaya M
Am J Physiol Lung Cell Mol Physiol; 2007 Dec; 293(6):L1427-36. PubMed ID: 17951314
[TBL] [Abstract][Full Text] [Related]
4. Genetic disruption of Fra-1 decreases susceptibility to endotoxin-induced acute lung injury and mortality in mice.
Vaz M; Reddy NM; Rajasekaran S; Reddy SP
Am J Respir Cell Mol Biol; 2012 Jan; 46(1):55-62. PubMed ID: 21816965
[TBL] [Abstract][Full Text] [Related]
5. Astragaloside IV modulates TGF-β1-dependent epithelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis.
Qian W; Cai X; Qian Q; Zhang W; Wang D
J Cell Mol Med; 2018 Sep; 22(9):4354-4365. PubMed ID: 29971947
[TBL] [Abstract][Full Text] [Related]
6. Nintedanib reduces ventilation-augmented bleomycin-induced epithelial-mesenchymal transition and lung fibrosis through suppression of the Src pathway.
Li LF; Kao KC; Liu YY; Lin CW; Chen NH; Lee CS; Wang CW; Yang CT
J Cell Mol Med; 2017 Nov; 21(11):2937-2949. PubMed ID: 28598023
[TBL] [Abstract][Full Text] [Related]
7. Surfactant protein D attenuates sub-epithelial fibrosis in allergic airways disease through TGF-β.
Ogawa H; Ledford JG; Mukherjee S; Aono Y; Nishioka Y; Lee JJ; Izumi K; Hollingsworth JW
Respir Res; 2014 Nov; 15(1):143. PubMed ID: 25472740
[TBL] [Abstract][Full Text] [Related]
8. Effects of doxycycline on production of growth factors and matrix metalloproteinases in pulmonary fibrosis.
Fujita H; Sakamoto N; Ishimatsu Y; Kakugawa T; Hara S; Hara A; Amenomori M; Ishimoto H; Nagata T; Mukae H; Kohno S
Respiration; 2011; 81(5):420-30. PubMed ID: 21502778
[TBL] [Abstract][Full Text] [Related]
9. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.
Kyung SY; Kim DY; Yoon JY; Son ES; Kim YJ; Park JW; Jeong SH
BMC Pharmacol Toxicol; 2018 Apr; 19(1):13. PubMed ID: 29609658
[TBL] [Abstract][Full Text] [Related]
10. Maresin 1 Inhibits Epithelial-to-Mesenchymal Transition in Vitro and Attenuates Bleomycin Induced Lung Fibrosis in Vivo.
Wang Y; Li R; Chen L; Tan W; Sun Z; Xia H; Li B; Yu Y; Gong J; Tang M; Ji Y; Yuan S; Shanglong Yao ; Shang Y
Shock; 2015 Nov; 44(5):496-502. PubMed ID: 26196843
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibitor restores surfactant protein-C expression in alveolar-epithelial type II cells and attenuates bleomycin-induced pulmonary fibrosis in vivo.
Ota C; Yamada M; Fujino N; Motohashi H; Tando Y; Takei Y; Suzuki T; Takahashi T; Kamata S; Makiguchi T; Yamaya M; Kubo H
Exp Lung Res; 2015; 41(8):422-34. PubMed ID: 26151196
[TBL] [Abstract][Full Text] [Related]
12. Soluble epoxide hydrolase inhibitor AUDA decreases bleomycin-induced pulmonary toxicity in mice by inhibiting the p38/Smad3 pathways.
Dong XW; Jia YL; Ge LT; Jiang B; Jiang JX; Shen J; Jin YC; Guan Y; Sun Y; Xie QM
Toxicology; 2017 Aug; 389():31-41. PubMed ID: 28694203
[TBL] [Abstract][Full Text] [Related]
13. Uridine supplementation exerts anti-inflammatory and anti-fibrotic effects in an animal model of pulmonary fibrosis.
Cicko S; Grimm M; Ayata K; Beckert J; Meyer A; Hossfeld M; Zissel G; Idzko M; Müller T
Respir Res; 2015 Sep; 16(1):105. PubMed ID: 26369416
[TBL] [Abstract][Full Text] [Related]
14. Protein tyrosine phosphatase α mediates profibrotic signaling in lung fibroblasts through TGF-β responsiveness.
Aschner Y; Khalifah AP; Briones N; Yamashita C; Dolgonos L; Young SK; Campbell MN; Riches DW; Redente EF; Janssen WJ; Henson PM; Sap J; Vacaresse N; Kapus A; McCulloch CA; Zemans RL; Downey GP
Am J Pathol; 2014 May; 184(5):1489-502. PubMed ID: 24650563
[TBL] [Abstract][Full Text] [Related]
15. Myeloid cell dynamics in bleomycin-induced pulmonary injury in mice; effects of anti-TNFα antibody.
Venosa A; Gow JG; Taylor S; Golden TN; Murray A; Abramova E; Malaviya R; Laskin DL; Gow AJ
Toxicol Appl Pharmacol; 2021 Apr; 417():115470. PubMed ID: 33647319
[TBL] [Abstract][Full Text] [Related]
16. c-Jun N-terminal kinase 1 is required for the development of pulmonary fibrosis.
Alcorn JF; van der Velden J; Brown AL; McElhinney B; Irvin CG; Janssen-Heininger YM
Am J Respir Cell Mol Biol; 2009 Apr; 40(4):422-32. PubMed ID: 18836136
[TBL] [Abstract][Full Text] [Related]
17. Development of pulmonary fibrosis through a pathway involving the transcription factor Fra-2/AP-1.
Eferl R; Hasselblatt P; Rath M; Popper H; Zenz R; Komnenovic V; Idarraga MH; Kenner L; Wagner EF
Proc Natl Acad Sci U S A; 2008 Jul; 105(30):10525-30. PubMed ID: 18641127
[TBL] [Abstract][Full Text] [Related]
18. The Transcription Factor FRA-1/AP-1 Controls Lipocalin-2 Expression and Inflammation in Sepsis Model.
Cao S; Schnelzer A; Hannemann N; Schett G; Soulat D; Bozec A
Front Immunol; 2021; 12():701675. PubMed ID: 34712224
[TBL] [Abstract][Full Text] [Related]
19. [Effects of andrographolide on the concentration of cytokines in BALF and the expressions of type I and III collagen mRNA in lung tissue in bleomycin-induced rat pulmonary fibrosis].
Zhu HL; Huang CL; Wang WJ; Zhan XQ; Fan XM
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jul; 27(7):725-9. PubMed ID: 21722520
[TBL] [Abstract][Full Text] [Related]
20. Endogenous annexin A1 counter-regulates bleomycin-induced lung fibrosis.
Damazo AS; Sampaio AL; Nakata CM; Flower RJ; Perretti M; Oliani SM
BMC Immunol; 2011 Oct; 12():59. PubMed ID: 22011168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
